Chronic Iron Overload Clinical Trial
Official title:
Open-label, Multicenter, Single Arm, Phase III Study to Collect Additional Safety and Efficacy Data With Deferasirox Film-coated Tablets in Patients Completing Study CICL670F2201
Extend evaluation of deferasirox film-coated tablet (FCT) formulation
Collection of additional safety and efficacy data with deferasirox film-coated tablet (FCT)
in patients who had completed study CICL670F2201
- Provide patients who completed 24 weeks of treatment in the core study, CICL670F2201,
the possibility to have additional treatment with the deferasirox FCT.
- Collect additional longer term data on the safety and the tolerability of the
deferasirox FCT.
- Collect efficacy data on the deferasirox FCT in reduction or maintenance of iron burden
as measured by serum ferritin level.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05440487 -
Study to Assess Iron Chelation Therapy in Patients With Chronic Iron Overload
|
||
| Not yet recruiting |
NCT06215287 -
Survey to Assess Physicians' Knowledge of Exjade Posology and Biological Monitoring Recommendations as Described in the Educational Materials
|
||
| Completed |
NCT01825512 -
Efficacy/Safety Study of Deferiprone Compared to Deferasirox in Paediatric Patients
|
Phase 3 | |
| Completed |
NCT01740713 -
Pharmacokinetic Study of Deferiprone in Paediatric Patients
|
Phase 2 |